Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GYN

[68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F]FDG

Bawinile Hadebe, Thembelihle Nxasana, Lerwine Harry, Maryam Patel, Nontobeko Ndlovu, Mpumelelo Msimang, Mike Sathekge, Siphelele Masikane, Lerato Gabela, Lerwine Harry and Mariza Vorster
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242218;
Bawinile Hadebe
1University of KwaZulu Natal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thembelihle Nxasana
1University of KwaZulu Natal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lerwine Harry
1University of KwaZulu Natal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Patel
2UKZN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nontobeko Ndlovu
2UKZN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mpumelelo Msimang
3NHLS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Sathekge
4Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siphelele Masikane
2UKZN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lerato Gabela
1University of KwaZulu Natal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lerwine Harry
5Inkosi Albert Luthuli Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariza Vorster
2UKZN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F]FDG
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F]FDG
Bawinile Hadebe, Thembelihle Nxasana, Lerwine Harry, Maryam Patel, Nontobeko Ndlovu, Mpumelelo Msimang, Mike Sathekge, Siphelele Masikane, Lerato Gabela, Lerwine Harry, Mariza Vorster
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242218;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F]FDG
Bawinile Hadebe, Thembelihle Nxasana, Lerwine Harry, Maryam Patel, Nontobeko Ndlovu, Mpumelelo Msimang, Mike Sathekge, Siphelele Masikane, Lerato Gabela, Lerwine Harry, Mariza Vorster
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242218;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prognostic Significance of Lymph Node Involvement in Cervical Cancer Patients with Negative Post-Treatment PET Scans
  • Intraindividual comparison of 68Ga-FAPI PET/CT with 18F-FDG PET/CT for imaging of cancer of the cervix.
  • Role of pre-operative FDG PET-CT scan in nodal and metastatic disease assessment in pelvic malignancies in treatment naive and post neoadjuvant chemotherapy setting.
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GYN

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire